by Chia Gemmato | Oct 27, 2023 | Healthcare, Healthcare Law, OIG Files
After glancing at the Halloween-themed graphic, I was tempted to rename this blog “The ‘Fraid’ Hunter” because that picture is horrifying. However, it did inspire me to discuss a healthcare horror tragedy. In this story, there are no bad guys,...
by Advize Admin | Jul 28, 2023 | Healthcare, Healthcare Law
The only government program that I can think of that did not authorize price negotiations for prescription medications was the Medicare Part D program. In its inception in 2006, price negotiations were not part of the law, and drug manufacturers were essentially at...
by Advize Admin | Jul 21, 2023 | Healthcare
Extending some of the recent prescription caps and data transparency requirements under the new Medicare payment rules, NJ has followed suit to place caps on some very important and needed medications, including insulin and EpiPens. If you recall, the price of...
by Advize Admin | Jun 22, 2023 | FWA, Healthcare
If you are an avid reader of our newsletter or blogs, you know that we focus on payment integrity, program integrity, fraud waste and abuse, and the cost/quality of healthcare. We are often talking about the business behind healthcare, and not necessarily the doctors...
by Advize Admin | Jun 16, 2023 | Commentary, Healthcare
Are you tired of tipping the “obligatory” 20%? I believe everyone (companies and people) should get paid what they deserve. I often tip 50% but sometimes I tip $1. It is performance based. Continuing on with international and summer...
by Advize Admin | Jun 16, 2023 | FWA, Healthcare
For those that remember Solaraze, it is one of the name brands for Diclofenac. Diclofenac is commonly known today as Voltaren. In 2018, the OIG conducted a study that reflected that there were some strong fraud indicators on the off-label use of Diclofenac (under...
Recent Comments